Among these DEGs, KRAS contributes to the leukemogenic transformation,21 and PTEN mutation occurs in 11.1% pediatric T-ALL patients as a tumor suppressor.22 The gene discussed is PTEN; the disease is acute lymphoblastic leukemia.